Orchid Pharma Ltd - 524372 - Board Meeting Outcome for Outcome Of The Board Meeting Held On May 23, 2024
outcome of the Board Meeting held on May 23, 202423-05-2024
23-05-2024
Orchid Pharma Ltd - 524372 - Audited Financial Results For Financial Year Ended On March 31, 2024
Audited Financial Results along with Auditor''s Report for Financial Year ended on March 31, 202423-05-2024
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst/ Investors Earning Call schedule to be held on Friday, May 24, 2024 at 04:00 P.M. (IST) to discuss the financial performance/ financial results of the Company for quarter/ year ended on March 31, 2024.17-05-2024
Orchid Pharma Ltd - 524372 - Board Meeting Intimation for Consideration And Approval Of Financial Results For The Period Ended March 31, 2024.
Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2024 ,inter alia, to consider and approve Audited Standalone & Consolidated Financial Results of the Company for the quarter and financial year ended on March 31, 2024.16-05-2024
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Monitoring Agency Report for the Quarter ended March 31, 202415-05-2024
Orchid Pharma Ltd - 524372 - Disclosure Regarding The Order Passed By Goods And Service Tax Department.
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 regarding an GST order received from office of Assistant Commissioner, Valluvarkottam, Central- III Chennai Central.02-05-2024
Orchid Pharma Ltd - 524372 - Compliance Certificate Under Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosures Requirements) Regulations, 2015, As Amended
Compliance Certificate under Regulation 7(3) of SEBI (LODR) Regulations, 2015, as amended.20-04-2024
Orchid Pharma Ltd - 524372 - Compliance Certificate Under Regulation 40(9) Of Securities And Exchange Board Of India (Listing Obligations And Disclosures Requirements) Regulations, 2015, As Amended
Compliance Certificate under Regulation 40(9) of SEBI (LODR) Regulations, 2015 as amended19-04-2024
Orchid Pharma Ltd - 524372 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 as amended.15-04-2024
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Resignation of Director
This is to inform that Mr. Mudit Tandon (DIN: 06417169) has tendered his resignation from the position of Independent Director of the Company w.e.f close of business hours of April 12, 2024. Also he has confirmed that there are no material reasons of resignation other than disclosed in the resignation letter.12-04-2024